Syneos Health at World Vaccine Congress Europe 2026

 Vaccine development is shaped by conditions that can change quickly, including disease activity, seasonality, site readiness, participant access and evolving evidence requirements. Successful programs anticipate these variables early and establish an operating model that can adapt as conditions change. 

Meet the Syneos Health vaccine team at World Vaccine Congress Europe 2026 to discuss how specialized expertise, epidemiological insights, predictive analytics and integrated delivery can support vaccine programs from early clinical development through commercialization. 

Meet with Us

Whether you are preparing an early vaccine study, expanding a global program or planning for commercialization, our experts can help you evaluate the clinical and operational decisions that will shape what comes next. 

Visit Syneos Health at Booth 236 or schedule time with our team during World Vaccine Congress Europe. 

Vaccine Expertise Across the Development Lifecycle 

The Syneos Health Global Vaccine and Emerging Infectious Disease Center of Excellence brings together clinical, medical, operational and commercial expertise across the vaccine development continuum. 

Our teams help sponsors: 

• Align study design, location and timing with epidemiology, seasonality and disease activity 

• Identify experienced sites and develop recruitment and retention strategies for populations ranging from neonates to older adults 

• Improve surveillance, case detection and visibility into study performance 

• Reduce participant and site burden through flexible support models and technology 

• Connect clinical evidence planning with market access, launch and commercialization strategy 

Predictability Built Into Vaccine Delivery 

PredictaVax™, our specialized vaccine operating model, connects study data and performance indicators to help teams identify trends, discrepancies and emerging risks earlier. Combined with infectious disease surveillance and predictive analytics, this approach supports timely decisions as epidemiological and operational conditions evolve.